Faculty Disclosures
| Justin T. Jordan, MD, MPH, FAAN |
Dr. Jordan has received personal compensation for serving as an employee of City of Beverly. An immediate family member of Dr. Jordan has received personal compensation for serving as an employee of Dietitians on Demand. An immediate family member of Dr. Jordan has received personal compensation for serving as an employee of Genesis HR Solutions. An immediate family member of Dr. Jordan has received personal compensation for serving as an employee of Harborlight Montesorri. Dr. Jordan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Navio Theragnostics. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Recursion Pharmaceuticals, Inc. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BCD Meetings. Dr. Jordan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Shepherd Therapeutics. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akeila Bio. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springworks Therapeutics. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Continental Casualty Company. Dr. Jordan has stock in Navio Theragnostics. Dr. Jordan has stock in The Doctor Lounge. An immediate family member of Dr. Jordan has stock in OldGate. Dr. Jordan has stock in Akeila Bio. The institution of Dr. Jordan has received research support from NIH. The institution of Dr. Jordan has received research support from Department of Defense. The institution of Dr. Jordan has received research support from PCORI. Dr. Jordan has received publishing royalties from a publication relating to health care. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Reimbursement for potential consultant role that was aborted with Magnet Biomedicine. Dr. Jordan has a non-compensated relationship as a board member with United Council for Neurologic Subspecialties that is relevant to AAN interests or activities. |
| Michelle Janelsins |
No disclosure on file
|
| Jan Drappatz, MD |
Dr. Drappatz has stock in Pfizer. Dr. Drappatz has stock in Vertex. Dr. Drappatz has stock in GSK. The institution of Dr. Drappatz has received research support from Servier. Dr. Drappatz has received publishing royalties from a publication relating to health care. |
| Nimish A. Mohile, MD, FAAN |
Dr. Mohile has nothing to disclose. |
| W. T. Kimberly, MD, PhD |
Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astrocyte Pharmaceuticals. Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acasti Pharma. Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hyperfine Inc.. Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurotherapeutics. Dr. Kimberly has stock in Woolsey Pharmaceuticals. Dr. Kimberly has stock in Acasti Pharma. The institution of Dr. Kimberly has received research support from Biogen. The institution of Dr. Kimberly has received research support from NControl Therapeutics. The institution of Dr. Kimberly has received research support from NIH. The institution of Dr. Kimberly has received research support from American Heart Association. The institution of Dr. Kimberly has received research support from Hyperfine, Inc.. Dr. Kimberly has received intellectual property interests from a discovery or technology relating to health care. |
| Sara Hardy, MD |
Dr. Hardy has received research support from the American Cancer Society. |
|
No disclosure on file
|
| Surabhi Ranjan, MD |
Dr. Ranjan has nothing to disclose. |
| Frank Lieberman, MD |
The institution of Dr. Lieberman has received research support from Novocure. The institution of Dr. Lieberman has received research support from Black Diamond. The institution of Dr. Lieberman has received research support from Chimerix. The institution of Dr. Lieberman has received research support from Abbvie. |
| Michael Milano |
No disclosure on file
|
| Yoshie A. Umemura, MD |
Dr. Umemura has received personal compensation for serving as an employee of Dignity Health. Dr. Umemura has received personal compensation for serving as an employee of University of Michigan. Dr. Umemura has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Servier. The institution of Dr. Umemura has received research support from Gateway for Cancer Research. |
| Dhivyaa Rajasundaram |
No disclosure on file
|
| Jaishri Blakeley, MD, FAAN |
Dr. Blakeley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Springworks Therapeutics. |
| Denise Leung, MD, MS |
Dr. Leung has stock in Enzo Ventures (real estate). An immediate family member of Dr. Leung has stock in Enzo Ventures (real estate). The institution of Dr. Leung has received research support from NCCN/Pfizer. |
| Deborah T. Blumenthal, MD |
Dr. Blumenthal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier Affaires Medicales. Dr. Blumenthal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure Israel Ltd. Dr. Blumenthal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda Oncology. The institution of Dr. Blumenthal has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Merck Sharp and Dohme. |
| Koren Holley |
Ms. Holley has nothing to disclose. |
| Olivia Michaels |
Ms. Michaels has nothing to disclose. |
| Lauryn Hemminger |
Dr. Hemminger has nothing to disclose. |
| Santosh Kesari, MD, PhD, FAAN |
Dr. Kesari has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for xcures. Dr. Kesari has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Duke. |
| Larry Junck, MD |
Dr. Junck has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orbus Therapeutics. Dr. Junck has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Brinker Doyen . Dr. Junck has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for O'Brien & Ryan. Dr. Junck has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Gidley Sarli & Marusak. Dr. Junck has received personal compensation in the range of $500-$4,999 for serving as a Expert evaluating a complaint involving faculty member with University of Minnesota. |
| Iben Spanggaard, MD, PhD |
Dr. Spanggaard has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. The institution of Dr. Spanggaard has received research support from Roche. The institution of Dr. Spanggaard has received research support from Genentech. The institution of Dr. Spanggaard has received research support from Astra-Zeneca. The institution of Dr. Spanggaard has received research support from Incyte. The institution of Dr. Spanggaard has received research support from Pfizer. The institution of Dr. Spanggaard has received research support from MSD. The institution of Dr. Spanggaard has received research support from PUMA Biotechnology. The institution of Dr. Spanggaard has received research support from Orion Pharma. Dr. Spanggaard has received personal compensation in the range of $500-$4,999 for serving as a Reimbursement for travel-related expenses for the AAN2023 with Incyte. |
| Matthew B. Bevers, MD, PhD |
Dr. Bevers has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for EBSCO. An immediate family member of Dr. Bevers has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Hinshaw Law. An immediate family member of Dr. Bevers has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Colorado Department of Law. The institution of Dr. Bevers has received research support from NINDS. The institution of an immediate family member of Dr. Bevers has received research support from AHRQ. The institution of an immediate family member of Dr. Bevers has received research support from NIH/Kowa Industries. |
| Scott R. Plotkin, MD, PhD, FAAN |
Dr. Plotkin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NFlection Therapeutics. Dr. Plotkin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Akouos. Dr. Plotkin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SonALAsense. Dr. Plotkin has stock in NFlection Therapeutics. Dr. Plotkin has stock in NF2 Therapeutics. Dr. Plotkin has stock in SonALAsense. Dr. Plotkin has received research support from Children's Tumor Foundation. Dr. Plotkin has received research support from Department of Defense. Dr. Plotkin has received research support from National Institutes of Health. Dr. Plotkin has received intellectual property interests from a discovery or technology relating to health care. |
| Jacqueline M. Behr, NP |
Mrs. Behr has nothing to disclose. |
| Jennifer N. Serventi, PA |
Ms. Serventi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novocure. |
| Maya Viera, Other |
Miss Viera has nothing to disclose. |
| Meredith Pescatello |
Mrs. Pescatello has nothing to disclose. |
| Elle Fietsam |
Miss Fietsam has nothing to disclose. |
| Ina Ly, MD |
An immediate family member of Dr. Ly has received personal compensation for serving as an employee of Enanta Pharmaceuticals. Dr. Ly has received research support from Department of Defense. An immediate family member of Dr. Ly has received intellectual property interests from a discovery or technology relating to health care. |
| Bruce R. Korf, MD |
Dr. Korf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SpringWorks Pharmaceuticals. Dr. Korf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Healx. Dr. Korf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Recursion. Dr. Korf has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genome Medical. Dr. Korf has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Infixion. Dr. Korf has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Journal of Human Genetics. Dr. Korf has stock in Genome Medical. The institution of Dr. Korf has received research support from NIH. The institution of Dr. Korf has received research support from Department of Defense. The institution of Dr. Korf has received research support from Children's Tumor Foundation. Dr. Korf has received publishing royalties from a publication relating to health care. Dr. Korf has received publishing royalties from a publication relating to health care. Dr. Korf has received publishing royalties from a publication relating to health care. |
| Ayah Al-Bzour |
Miss Al-Bzour has nothing to disclose. |
| Ghayda'a N. Al-Majali |
Ms. Al-Majali has nothing to disclose. |
| Saja Alzghoul |
Miss Alzghoul has nothing to disclose. |
| Yaman Ahmed |
Mr. Ahmed has nothing to disclose. |
| Zaid M. Khalefa |
Mr. Khalefa has nothing to disclose. |
| Karisa C. Schreck, MD, PhD |
Dr. Schreck has received personal compensation in the range of $0-$499 for serving as a Consultant for Nurix. Dr. Schreck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Schreck has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Advarra LLC. The institution of Dr. Schreck has received research support from Springworks Therapeutics. Dr. Schreck has received personal compensation in the range of $500-$4,999 for serving as a speaker with Springworks Therapeutics. |
| Ingo K. Mellinghoff, MD, FACP |
Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Agios. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Black Diamond Therapeutics. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Voyager Therapeutics . Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kazia Therapeutics. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier . Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Agios. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Black Diamond Therapeutics. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Debiopharm Group. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Puma Biotechnology. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Voyager Therapeutics. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DC Europa Ltd. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kazia Therapeutics. Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Dr. Mellinghoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cardinal Health. Dr. Mellinghoff has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier . Dr. Mellinghoff has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ASCO/JCO. The institution of Dr. Mellinghoff has received research support from Amgen. The institution of Dr. Mellinghoff has received research support from General Electric. The institution of Dr. Mellinghoff has received research support from Lilly. The institution of Dr. Mellinghoff has received research support from Kazia Therapeutics. An immediate family member of Dr. Mellinghoff has received research support from Vigeo Therapeutics. The institution of an immediate family member of Dr. Mellinghoff has received research support from Samus Therapeutics. The institution of Dr. Mellinghoff has received research support from Erasca . |
| Ashley P. Ghiaseddin, MD, FAAN |
Dr. Ghiaseddin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Ghiaseddin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neosoma. Dr. Ghiaseddin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. Dr. Ghiaseddin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aptitude Health. Dr. Ghiaseddin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris Medical. Dr. Ghiaseddin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ONO Pharma USA. Dr. Ghiaseddin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Ghiaseddin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global Consulting. Dr. Ghiaseddin has stock in Viatris Inc. |
| Alissa A. Thomas, MD, FAAN |
The institution of Dr. Thomas has received research support from Novocure. The institution of Dr. Thomas has received research support from Ono Pharmaceuticals. |
| Obada Ababneh |
Mr. Ababneh has nothing to disclose. |
| Michal Nisnboym Ziv, MD |
Dr. Nisnboym Ziv has nothing to disclose. |